Popular Articles
Stretch Mark Cream

ARYx Therapeutics Inc. Updates Progress With Tecarfarin EmbraceAC Study
ARYx Therapeutics Inc. (NASDAQ:ARYX), a biopharmaceutical company, announced today that the database for the EmbraceAC study has been locked and the study remains on schedule, with the efficacy and safety results to be available during the week of July 6, 2009. The study was designed to compare its oral anticoagulation therapy, tecarfarin (previously ATI-5923), against the leading anticoagulant agent, warfarin. The purpose of the trial is to evaluate whether tecarfarin is superior to warfarin in its ability to maintain patients within a target therapeutic range of the level of anticoagulation as measured by INR (International Normalized Ratio). Based upon recent interactions with the U. S. Food and Drug Administration (FDA), ARYx believes this trial could be positioned as one of the required registration studies for tecarfarin.
generic viagra online
House Education-Labor Panel Passes Health Reform Bill, Rejects Amendments To Ban Abortion Coverage
The House Education and Labor Committee on Friday voted 26-22 to approve the House health reform bill (HR 3200) after adopting 20 amendments, many of which sought to expand the scope of coverage and increase the number of U.S. residents eligible for purchasing coverage through a health insurance exchange, CQ Today reports. The panel voted 19-28 to reject two amendments offered by Rep. Mark Souder (R-Ind.) that would have precluded plans participating in the health insurance exchange -- including the proposed public insurance plan -- from covering abortion services. The committee agreed to allow some existing state and federal programs to obtain waivers from the bill"s requirements. Among the approved amendments was a 400-page amendment by committee Chair George Miller (D-Calif.) that would open the exchange to more small businesses, certain retirees, and families whose premiums and out-of-pocket costs total more than 11% of their income. The amendment was adopted by voice vote (Demirjian, CQ Today, 7/17). Purchase zoloft to treat depression.
News of the day
South African President Addresses Increased Access To Antiretrovirals, Reduction In HIV Incidence
South African President Jacob Zuma on Wednesday said he wants to have 80 percent of HIV-positive South Africans who need antiretrovirals (ARVs) on them by 2011, BuaNews reports (BuaNews/allAfrica.com, 6/3). The announcement was part of Zuma"s first state-of-the-nation address, when he discussed ways the government would strive to "step up measures to improve health care in Africa"s strongest economy," Reuters writes. "We have set ourselves the goals of reducing inequalities in health care ... and step up the fight against the scourge of HIV and AIDS, TB and other diseases," Zuma said (Roelf, Reuters, 6/4).
Health Insurance

New Tool Helps Researchers Identify DNA Patterns Of Cancer, Genetic Disorders

A new tool will help researchers identify the minute changes in DNA patterns that lead to cancer, Huntington"s disease and a host of other genetic disorders. The tool was developed at North Carolina State University and translates DNA sequences into graphic images, which allows researchers to distinguish genetic patterns more quickly and efficiently than was historically possible using computers. David Cox, a Ph.D. student in computer science at NC State, devised the "symbolic scatter plot" tool to provide a visual representation of a DNA sequence. Cox explains, "The human visual system is more adept at identifying patterns, and differentiating between patterns, than existing computer programs such as those that try to identify repetitions of DNA sequences." In other words, the naked eye sees patterns better than computers can. Identifying patterns in a sequence of DNA is important because it can help researchers identify the minute genetic variations between subjects that suffer from a disease, such as cancer, and subjects that do not. "Improved identification of relevant DNA sequences will hopefully expedite the development of successful treatment for a range of diseases," Cox says, "by allowing researchers to focus on the components of DNA that are related to the disease and improving our understanding of the genetic mechanisms of these diseases. For example, what turns specific genes on and off?" So, how does the symbolic scatter plot create a visual representation of DNA? DNA is composed of a series of nucleotides. There are only four types of nucleotides, represented by the letters A, T, G and C. Each three-letter string of these nucleotides, such as AAA or ATG, is called a 3-mer. Cox explains, "There are only 64 possible 3-mers, thus each 3-mer maps to a number from zero to 63. The symbolic scatter plots take a very long string of letters representing a DNA sequence and split it into a bunch of 3-mers. It then plots a point for each 3-mer, zero through 63, with that number serving as the y-coordinate." The x-axis is the order that the 3-mer appears in the genetic sequence. "If this seems really simple," Cox says, "that"s because it really is simple. Even so, the resulting scatter plots reveal interesting patterns in the original DNA. I can also string these scatter plots together to produce animations for the purpose of comparing DNA sequences." Cox chose to focus on 3-mers because they correlate to codons, which are the genetic codes the body uses to specify the insertion of a specific amino acid during the creation of proteins. In other words, they oversee the creation of proteins - which are themselves the basic building blocks of the human body. "There are 64 3-mers, but only 20 amino acids," Cox says, "so each amino acid corresponds to multiple 3-mers." Cox designed the symbolic scatter plot so that those 3-mers that correspond to the same amino acid are adjacent to one another. "This way," Cox says, "it is easier to determine when a difference in 3-mers is significant - from one amino acid to another - rather than a difference in 3-mers that still results in the production of the same amino acid. A change in a single amino acid can be the difference between a relatively harmless disease and a fatal one," Cox says. Cox will present the research this July at BIOCOMP "09 - The 2009 International Conference on Bioinformatics and Computational Biology in Las Vegas. The research was co-authored by Dr. Lina Dagnino of the University of Western Ontario. Matt Shipman North Carolina State University


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):